Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.76 USD | +2.40% | -1.26% | +122.83% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.83% | 598M | |
+22.81% | 44.96B | |
+0.76% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.93% | 26.08B | |
-21.22% | 19.03B | |
+6.32% | 12.75B | |
+28.78% | 12.06B | |
-3.41% | 11.75B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Stoke Therapeutics Prices Upsized $125 Million Share Offering